跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 155 条关于
“Menarini Stemline”
全部
155
临床试验
39
药物
1
机构
18
资讯
97
去年
NHS Rejects Elacestrant (Korserdu) for Advanced Breast Cancer with ESR1 Mutation
9个月前
Menarini Group to Present New ELZONRIS Data at ASH 2025, Including Promising Triplet Therapy Results for BPDCN
去年
ADELA Phase III Trial Explores Elacestrant and Everolimus Combination for Advanced Breast Cancer
6个月前
Medidata and Menarini Group Expand AI-Powered Partnership to Accelerate Oncology Clinical Trials
3个月前
Menarini Group to Present Comprehensive Oncology Data at ASCO 2026, Featuring Elacestrant Combination Studies
去年
First Patient Dosed in Phase II JASPIS-01 Trial of Dapolsertib for Relapsed/Refractory DLBCL
去年
ERBC and Menarini Biotech Form Strategic Alliance to Accelerate Biopharmaceutical Development
9个月前
Elacestrant Combination Therapy Shows Promising Progression-Free Survival Results in ER+ Metastatic Breast Cancer
上个月
Menarini Asia-Pacific to Commercialise Cosela (trilaciclib) Across Multiple APAC Markets, First Launch Anticipated in Hong Kong in 2028
去年
NewAmsterdam's Obicetrapib Receives EMA Validation for European Review Following Positive Phase 3 Results
第 1 页,共 10 页
上一页
下一页